µ±Ç°Î»ÖãºÊ×Ò³ > ²úÆ·ÖÐÐÄ > > ±±ÆôÊÔ¼ÁºÐ > ±±ÆôÉúÎﻯѧÖرà³ÌÊÔ¼ÁºÐ
¼òÒªÃèÊö£º±±ÆôÉúÎﻯѧÖرà³ÌÊÔ¼ÁºÐ»ùÓÚ±±¾©´óѧµËºê¿ý½ÌÊÚÍŶÓеÄÍ»ÆÆÐԳɹû¡°ÀûÓû¯Ñ§Ð¡·Ö×ÓÓÕµ¼È˳ÉÌåϸ°ûת±äΪ¶àÄܸÉϸ°û¡°¿ª·¢£¬¿ÉÎȶ¨¡¢¸ßЧµØ½«È˳ÉÌåÖ¬·¾À´Ô´µÄ»ùÖÊϸ°ûºÍƤ·ô³ÉÏËάϸ°ûÖرà³ÌΪÈË»¯Ñ§ÓÕµ¼µÄ¶àDZÄܸÉϸ°û£¨¼ò³ÆÈËCiPSϸ°û£©¡£³ý»¯Ñ§Öرà³ÌÓÕµ¼È˶àDZÄܸÉϸ°û£¨CiPSC£©ÖƱ¸ÊÔ ¼ÁºÐÍ⣬¹«Ë¾Í¬Ê±³É¹¦¿ª·¢³öÁË¿ÆÑÐÒÔ¼°ÁÙ´²GMP¼¶±ðÖÖ×Óϸ°û£¬²¢Õýʽ¿ªÊ¼¶ÔÍ⿪չÉÌÎñºÏ×÷¡£
²úÆ··ÖÀà
Ïêϸ½éÉÜ
BeiCell™ £¨±±ÆôÉúÎÈË»¯Ñ§Öرà³ÌÓÕµ¼¶àDZÄܸÉϸ°ûÊÔ¼ÁºÐ
--±±¾©´óѧµËºê¿ý½ÌÊÚÍŶÓеÄÍ»ÆÆÐԳɹû
±±ÆôÉúÎﻯѧÖرà³ÌÓÕµ¼¶àDZÄܸÉϸ°ûÊÔ¼ÁºÐ»ùÓÚ±±¾©´óѧµËºê¿ý½ÌÊÚÍŶÓеÄÍ»ÆÆÐԳɹû¡°ÀûÓû¯Ñ§Ð¡·Ö×ÓÓÕµ¼È˳ÉÌåϸ°ûת±äΪ¶àÄܸÉϸ°û(Nature, 2022; Cell Stem Cell, 2023)"¿ª·¢£¬¿ÉÎȶ¨¡¢¸ßЧµØ½«È˳ÉÌåÖ¬·¾À´Ô´µÄ»ùÖÊϸ°û(ADSC)ºÍƤ·ô³ÉÏËάϸ°û(Fibroblast)Öرà³ÌΪÈË»¯Ñ§ÓÕµ¼µÄ¶àDZÄܸÉϸ°û(human chemically induced pluripotent stem cells£¬¼ò³Æ ¡°ÈËCiPSϸ°û")¡£
»¯Ñ§Öرà³ÌÊÇÓɱ±¾©´óѧµËºê¿ý½ÌÊÚÍŶÓ×ÔÖ÷Ñз¢µÄÐÂÒ»´úÈ˶àÄܸÉϸ°ûÖƱ¸¼¼Êõ£¬Ïà¶ÔÓÚ´«Í³¡°Ìåϸ°ûºËÒÆÖ²"ºÍ¡°×ª»ùÒò¹ý±í´ïת¼Òò×Ó"Öرà³ÌÖƱ¸¶àÄܸÉϸ°û£¬»¯Ñ§Öرà³Ì¸ü¼Ó¼òµ¥¡¢¸ßЧºÍ°²È«£¬ÎªÎÒ¹ú¸Éϸ°ûºÍÔÙÉúҽѧµÄ·¢Õ¹½â¾öÁ˵ײ㼼ÊõÉϵġ°Æ¿¾±"ÎÊÌ⡣Ŀǰ£¬¸ÃÏîÇ°Ñؼ¼ÊõÓɱ±¾©±±ÆôÉúÎïÒ½Ò©ÓÐÏÞ¹«Ë¾ÊÚȨת»¯¡£³ý»¯Ñ§Öرà³ÌÓÕµ¼È˶àDZÄܸÉϸ°û£¨CiPSC£©ÖƱ¸ÊÔ¼ÁºÐÍ⣬¹«Ë¾Í¬Ê±³É¹¦¿ª·¢³öÁË¿ÆÑÐÒÔ¼°ÁÙ´²GMP¼¶±ðÖÖ×Óϸ°û£¬²¢Õýʽ¿ªÊ¼¶ÔÍ⿪չÉÌÎñºÏ×÷£¬ÖîÈç¿ÉÓÃÓÚÌåÍâÒ©Îïɸѡ£¬ÀàÆ÷¹Ù·Ö»¯ÒÔ¼°ÁÙ´²Ò©Îï¹ÜÏß¿ª·¢µÈÓ¦ÓÃÁìÓò¡£
¼òµ¥
²Ù×÷·½±ã£¬½öͨ¹ý¼òµ¥µÄ»»Òº²Ù×÷¼´¿ÉʵÏÖÖرà³Ì¡£
¸ßЧ
ÓÕµ¼Ð§Âʸߣ¬Æ¤·ô³ÉÏËάϸ°ûÖرà³ÌЧÂÊΪ0.4%-6.8%£¬Ö¬·¾×éÖ¯À´Ô´µÄ»ùÖÊϸ°ûÖرà³ÌЧÂÊΪ1%-31%¡£
Îȶ¨
²»Í¬ÒÅ´«±³¾°¡¢²»Í¬ÄêÁä¸öÌåÀ´Ô´µÄÌåϸ°û¾ù¿ÉʵÏÖ¸ßЧÓÕµ¼¡£
Ò×ÓÚ±ê×¼»¯
³É·ÖÃ÷È·£¬²»ÒÀÀµÑªÇåºÍËÇÑø²ãϸ°û£¬Ò×ÓÚ±ê×¼»¯¡£
°²È«
»¯Ñ§Ð¡·Ö×Ó²»ÕûºÏµ½»ùÒò×飬ÎÞÃâÒßÔÐÔ£¬Ïà¶ÔÓÚת»ùÒò¼¼Êõ¸ü¼Ó°²È«¡£
±±ÆôÉúÎﻯѧÖرà³ÌÊÔ¼ÁºÐ
±±ÆôÉúÎﻯѧÖرà³ÌÊÔ¼ÁºÐ
²úÆ·×Éѯ
»¶ÓÄú¹Ø×¢QYǧÒÚ¹ú¼ÊµÄ΢ÐŹ«ÖÚºÅÁ˽â¸ü¶àÐÅÏ¢